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BACKGROUND 
We recently published a research article summarising visits made to secondary care 
specialists by children and young people prescribed antidepressants in primary care in 
England[1]. In a commentary on this article[2], Walkup and Strawn agree with us that 
there is a substantial gap in care of depression and anxiety in children and young people, 
but also argue that studies such as ours may actually make it harder to access evidence-
based care. In response, we make the case that descriptive epidemiological studies such 
as ours, which summarise the current state of play and illustrate unmet healthcare needs, 
are vital in making the case to policy makers for improvements in care provision. 
FINDINGS HIGHLIGHTED THROUGH DESCRIPTIVE EPIDEMIOLOGY 
Our paper was intentionally neutral on the long-running debate about the benefits and 
risks of prescribing antidepressants to treat depression and anxiety in children and young 
people. The balance of this debate is likely to differ between countries with different rates 
of prescribing and systems of healthcare delivery. Instead, we used the National Institute 
for Health and Care Excellence (NICE) Guideline for depression in children and young 
people [CG134][3] as a benchmark to compare against current UK practice. The purpose 
of these guidelines is to provide best-practice treatment guidance tailored to the UK 
setting, based on the best available evidence and expert consensus. By summarising 
the differences between current guidelines and actual practice, we demonstrate 
weaknesses in the current approach which those involved in developing guidelines, and 
the policy makers who implement guidelines, should take note of. Why is it that general 
practitioners are prescribing antidepressants but not referring children and young people 
to mental health specialists as recommended? Is this a problem? Our study cannot 
answer these questions, but it does highlight the need to address them and understand 
why clinical practice deviates from guidance. 
A second problem highlighted by our study is an information gap. It is difficult to describe 
clearly the current structure of child and adolescent mental health services in the UK, let 
alone know whether the right young people are getting the right treatment by 
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summarising treatment needs and rates of access to treatment. Recent reports by the 
Children’s Commissioner for England on access to mental health services[4, 5] relied on 
the Mental Health Services Data Set, which they describe as having “certain limitations 
in terms of the quality and completeness of data”, or on freedom of information requests. 
In our own study it was not possible to determine the reasons for antidepressant 
prescribing for a large proportion of patients. As we say in our paper, this does not 
necessarily imply poor medical practice. It does, however, make it difficult to determine 
the true scale of any treatment gaps for particular conditions. This could be seen as a 
problem for epidemiologists rather than clinicians and policymakers, but improved 
routine data collection regarding mental health diagnosis and treatment indications 
would make it much easier to understand current demand for services, where the gaps 
are, and how to improve care provision.  
CONCLUSIONS 
In summary, it seems reasonable that treatment guidance should reflect i) the best 
available evidence, ii) the current needs of the population, and iii) the availability of 
resources and organisation of services. Understanding the current needs of the 
population and where resources are most needed should help tailor care provision to the 
real world. Arguably, therefore, access to evidence-based care for large numbers of 
children with anxiety and depression can be improved rather than inhibited by good 
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